Archive for February, 2008
Prostate cancers that are resistant to androgen deprivation therapy are more invasive and more likely to spread to other organs than androgen dependent prostate cancers, UCLA cancer researchers have f
More: continued here
In February 2004, the Food and Drug Administration approved the use of pemetrexed (brand name Alimta) for the treatment of malignant pleural mesothelioma
More: continued here
1000 Hotel Seattle Wa Alimta Mesothelioma
More: continued here
Boilermakers may be at risk of acquiring fatal mesothelioma
More: continued here
A national media campaign alerting women to the symptoms of ovarian cancer will be launched today as new survey results reveal many Australian women are unaware of the warning signs of Australia&rsquo
More: continued here
One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system’s attack on cancer cells is that many patients whose tumours recede in response to the treatm
More: continued here
asbestosis mesothelioma
More: continued here
In February 2004, the United States Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma
More: continued here
Researchers have found that multiple myeloma patients given the anti-cancer drug Velcade (bortezomib) in combination with a more commonly used drug showed a fourfold increase in complete remission rat
More: continued here
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending the extension of the license of pemetrexed (Alimta®) to include the first line treatment in …
More: continued here
- April 2008 (109)
- March 2008 (75)
- February 2008 (94)
- January 2008 (90)
- December 2007 (61)
- November 2007 (75)
- October 2007 (101)
- September 2007 (131)
